The stock of Healthcare Realty Trust Incorporated (NYSE:HR) increased by $0.25 on Tuesday to finish at $16.99, up 1.49 percent. The last five days have seen an average of 2,266,600 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$2.28. The average number of shares traded over the last 20 days was 2,660,315, while the average volume over the last 50 days totaled 2,338,404.
HR stock dropped -13.01% since last month. On 08/22/23, the company’s shares reached a one-month low of $16.50. The stock touched a high of $25.42 on 02/02/23, after rallying from a low of $16.50 in 52 weeks. The price of HR stock has declined by -11.83% or -$2.28 this year, reaching a new high 9 times. Still, the stock price is down -33.15% from the 52-week high.
Insider Transactions
HR stock investors should be aware that Healthcare Realty Trust Incorporated (HR) stock had its last reported insider trading activity 14 days ago on Aug 16. On Aug 16, Director SINGLETON JOHN KNOX acquired 31,500 shares at $17.11 each. This transaction resulted in the insider spending $538,965. On Mar 08, Kilroy James Joseph IV added 2,400 shares at a price of US$19.02. After the transaction, the insider now owns 26,601 shares. Director Kilroy James Joseph IV had earlier bought 10,000 shares on Mar 06 for $19.27 a share. The transaction was completed for $192,700.
Valuation Metrics
Beta for the stock is 0.79. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.96, the price-to-book (PB) ratio of 0.90.
Company paid $0.31 per share in dividends, remained unchanged from $0.31 last year. A $0.2010 dividend increase was reported on Wednesday November 2 2022.
Financial Health
The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.75, and the total debt to equity ratio is 0.75. As far as profitability goes, gross margin for the trailing twelve months is 63.70% percent. Healthcare Realty Trust Incorporated’s operating margin stood at -11.90% for the same period. Based on annual data, it had gross profit of -$23.83 million and revenue of $932.64 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. HR’s return on assets (ROA) during the last 12 months has been -1.30%. There was a -0.60% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -2.40%.
Earnings Surprise
According to Healthcare Realty Trust Incorporated’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $338.14 million, while revenues rose by 57.02% to $332.93 million. It was predicted that Healthcare Realty Trust Incorporated’s quarterly earnings would be -$0.22, but it ended up being -$0.13, beating the consensus by -69.20%. EBITDA was $216.58 million for the quarter. At the end of Healthcare Realty Trust Incorporated’s most recent quarter ended June 29, its total debt was $5.69 billion. Equity owned by shareholders amounts to $380.86 million.
Technical Picture
Here’s a quick look at Healthcare Realty Trust Incorporated’s (HR) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 36.86%, suggesting the stock is Neutral, with a 15.05% historical volatility rate.
The stochastic %K and %D were 12.08% and 9.58% respectively, while the average true range (ATR) was 0.39. Based on the 14-day stochastic reading of 20.74%, the RSI (14) reading is 34.44%. On the 9-day MACD Oscillator, the stock is at 0.00, and the 14-day reading is at -0.26.
Analyst Ratings
In its analyst report released on April 20, 2023, Wells Fargo began covering Healthcare Realty Trust Incorporated (NYSE: HR). The stock was rated as an Equal weight by the brokerage firm. Analysts have assigned Healthcare Realty Trust Incorporated (HR) an Hold rating. HR is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 2 others recommend it as a buy.
What is HR’s price target for the next 12 months?
The current consensus forecast for the stock is between $17.00 and $24.00, with a median target price of $21.50. In analyzing these forecasts, the average price target given by analysts for Healthcare Realty Trust Incorporated (HR) is $21.00.
